NASDAQ:NOVN - Novan Stock Price, Forecast & News

Novan trades on the NASDAQ under the ticker symbol "NOVN."

Novan Inc (NASDAQ:NOVN) issued its quarterly earnings data on Friday, May, 12th. The company reported ($0.73) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.49) by $0.24. The firm earned $0.10 million during the quarter, compared to analyst estimates of $10.80 million. View Novan's Earnings History.

Novan is scheduled to release their next quarterly earnings announcement on Wednesday, March 25th 2020. View Earnings Estimates for Novan.

3 brokerages have issued twelve-month target prices for Novan's stock. Their forecasts range from $0.50 to $1.50. On average, they expect Novan's stock price to reach $1.00 in the next year. This suggests a possible upside of 354.8% from the stock's current price. View Analyst Price Targets for Novan.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novan in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Novan.

Media stories about NOVN stock have been trending very negative recently, InfoTrie reports. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Novan earned a news impact score of -4.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the next few days. View News Stories for Novan.

Novan saw a increase in short interest in the month of February. As of February 14th, there was short interest totalling 399,500 shares, an increase of 111.7% from the January 30th total of 188,700 shares. Based on an average daily volume of 495,900 shares, the short-interest ratio is presently 0.8 days. Approximately 2.4% of the shares of the stock are sold short. View Novan's Current Options Chain.

Some companies that are related to Novan include Alimera Sciences (ALIM), Guardion Health Sciences (GHSI), Adamis Pharmaceuticals (ADMP), RegeneRx Biopharmaceuticals (RGRX), Acer Therapeutics (ACER), Annovis Bio (ANVS), Evoke Pharma (EVOK), Fibrocell Science (FCSC), Moleculin Biotech (MBRX), Akari Therapeutics (AKTX), Jaguar Health (JAGX), China SXT Pharmaceuticals (SXTC), Celsion (CLSN), Pulmatrix (PULM) and Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (ZOM).

Based on aggregate information from My MarketBeat watchlists, some companies that other Novan investors own include Melinta Therapeutics (MLNT), SCYNEXIS (SCYX), MannKind (MNKD), Trevena (TRVN), Vuzix (VUZI), Valero Energy (VLO), Washington Prime Group (WPG), Biocept (BIOC), Cirrus Logic (CRUS) and Heron Therapeutics (HRTX).

(NOVN) raised $46 million in an IPO on Wednesday, September 21st 2016. The company issued 3,800,000 shares at $11.00-$13.00 per share. Piper Jaffray served as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

Novan's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Cardinal Capital Management (0.19%) and Vigilant Capital Management LLC (0.11%). Company insiders that own Novan stock include G Kelly Martin, John M Gay, John W Palmour, Life Sciences Holdings L Malin, Paula B Stafford and Robert Alexander Ingram. View Institutional Ownership Trends for Novan.

NOVN stock was purchased by a variety of institutional investors in the last quarter, including Cardinal Capital Management and Vigilant Capital Management LLC. Company insiders that have bought Novan stock in the last two years include G Kelly Martin, John M Gay, John W Palmour, Paula B Stafford and Robert Alexander Ingram. View Insider Buying and Selling for Novan.

Shares of NOVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NOVN stock can currently be purchased for approximately $0.22.

Novan has a market capitalization of $6.03 million and generates $4.90 million in revenue each year. The company earns $-12,670,000.00 in net income (profit) each year or ($1.13) on an earnings per share basis. Novan employs 47 workers across the globe.View Additional Information About Novan.

The official website for Novan is http://www.novantherapeutics.com/.

Novan's mailing address is 4105 HOPSON ROAD, MORRISVILLE NC, 27560. The company can be reached via phone at 919-485-8080 or via email at [email protected]